Life Molecular Imaging SA

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sionna Gets CF Compounds AbbVie License

As Biogen, Inc. and Eisai Co., Ltd. bask in the glow of the US Food and Drug Administration’s full approval of Leqembi (lecanemab-irmb), Andrea Pfeifer, CEO of Swiss biotech AC Immune SA , sees i

Faced with continuing failure in Alzheimer’s drug development, researchers are grappling with the best route forward. And as efforts to modify disease progression or even better symptomatic treatment

According to the Alzheimer’s Association, Alzheimer’s disease is the sixth leading cause of death in the US, and is the only one among the top 10 that cannot be prevented, cured or slowed. This year A